Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

After more than a decade of dog treats and deliveries, a UPS driver in Georgia shared an emotional moment with a couple of ...

MIT and Scripps scientists explore a single-dose vaccine approach by combining two immune-boosting ingredients.

Results from the Phase III SUNMO trial show that the Lunsumio and Polivy combination achieved statistically significant ...

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with ...

A panelist discusses recent advancements in bispecific antibody therapies for relapsed/refractory multiple myeloma, ...

Our immune systems don't always react in the right way, but scientists are learning more about why that happens... | Genetics And Genomics ...

Now, scientists say the woman is the only known carrier of a new blood type called “Gwada negative.” It’s the only blood type ...

These activities are further supported by the in-vivo data demonstrating that both the NKG2A and CD3 arms contribute to the ...

Aedes aegypti mosquitoes, known for spreading diseases, exhibit remarkable adaptability by using heat detection when their ...

Roche and Genentech have announced outcomes from the randomised, multi-centre, international Phase III SUNMO trial for those ...

Datroway received accelerated FDA approval for adults with EGFR+ advanced non-small cell lung cancer after EGFR-targeted and ...